| Management number | 233459827 | Release Date | 2026/06/27 | List Price | US$87.20 | Model Number | 233459827 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
The therapeutic targeting of miRNAs in RCC has opened new avenues for treatment, offering the possibility of more specific and less toxic interventions. With the ability to manipulate miRNA expression through mimics or inhibitors, we may soon be able to complement traditional treatments such as surgery and immunotherapy, addressing issues such as drug resistance and metastasis. Additionally, the integration of miRNA-based biomarkers into clinical practice could lead to more personalized treatment regimens, optimizing patient outcomes and minimizing unnecessary side effects. Read more
| ASIN | B0DT4CX24H |
|---|---|
| ISBN13 | 979-8306855905 |
| Language | English |
| Publisher | Independently published |
| Dimensions | 8.5 x 0.34 x 11 inches |
| Item Weight | 15.8 ounces |
| Reading age | Baby - 18 years |
| Print length | 147 pages |
| Publication date | January 13, 2025 |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form